Valuation Vertex Pharmaceuticals Incorporated

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 12/06/2026 BST			5-day change	1st Jan Change
444.92 ^USD	-0.03%		-0.43%	-1.86%

06-11	Vertex's Late-Stage Clinical Data of Casgevy Deliver Crisis-Free, Transfusion-Free Results in Kids With Blood Disorders	MT
06-11	Vertex Pharmaceuticals Incorporated Presents New Data on Casgevy and Announces Additional Global Regulatory Submissions	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	55,834	74,127	104,849	103,707	115,026	112,924	-	-
Change	-	32.76%	41.44%	-1.09%	10.91%	-1.83%	-	-
Enterprise Value (EV) ¹	48,309	63,349	93,630	97,591	108,418	100,140	95,790	91,423
Change	-	31.13%	47.8%	4.23%	11.09%	-7.64%	-4.34%	-4.56%
P/E Ratio	24.4x	22.5x	29.3x	-194x	29.6x	25.4x	22.6x	19.3x
PBR	5.53x	5.33x	5.96x	6.4x	6.17x	5.11x	4.25x	3.59x
PEG	-	0.5x	3.51x	2x	-0x	1.8x	1.8x	1.1x
Capitalization / Revenue	7.37x	8.3x	10.6x	9.41x	9.58x	8.66x	7.92x	7.13x
EV / Revenue	6.38x	7.09x	9.49x	8.86x	9.03x	7.68x	6.71x	5.77x
EV / EBITDA	10.8x	12.8x	20.6x	108x	19.8x	17.3x	14.4x	12x
EV / EBIT	11.1x	13.2x	21.4x	140x	20.6x	18x	15.2x	12.5x
EV / FCF	20.1x	16.1x	28.1x	-123x	33.9x	20.6x	18.6x	16.2x
FCF Yield	4.99%	6.2%	3.56%	-0.81%	2.95%	4.84%	5.37%	6.18%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	9.01	12.82	13.89	-2.08	15.32	17.49	19.71	23.03
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,038	14,267	15,840
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	5,782	6,651	7,618
EBIT ¹	4,344	4,793	4,375	695.6	5,263	5,554	6,319	7,333
Net income ¹	2,342	3,322	3,620	-535.6	3,953	4,451	5,053	5,979
Net Debt ¹	-7,525	-10,778	-11,218	-6,116	-6,608	-12,785	-17,134	-21,501
Reference price ²	219.60	288.78	406.89	402.70	453.36	444.92	444.92	444.92
Nbr of stocks (in thousands)	254,252	256,691	257,683	257,529	253,719	253,805	-	-
Announcement Date	26/01/22	07/02/23	05/02/24	10/02/25	12/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	25.44x	7.68x	17.32x	-.--%	113B
ELI LILLY AND COMPANY	33.15x	12.05x	24.81x	0.6%	1,010B
JOHNSON & JOHNSON	25.74x	5.93x	16.13x	2.22%	580B
ABBVIE INC.	27.88x	6.79x	13.86x	3.01%	402B
ROCHE HOLDING AG	17.71x	4.37x	10.73x	3.04%	330B
NOVARTIS AG	21.24x	5.49x	13.32x	2.92%	281B
ASTRAZENECA PLC	22.78x	4.74x	13.47x	1.85%	280B
NOVO NORDISK A/S	12.7x	4.76x	9.73x	3.95%	197B
AMGEN INC.	23.09x	6.16x	10.76x	2.84%	192B
GILEAD SCIENCES, INC.	-45x	5.43x	29.95x	2.58%	156B
Average	16.47x	6.34x	16.01x	2.3%	354.19B
Weighted average by Cap.	22.76x	7.48x	17.41x	2.03%